CVR number 10033365
Industry 32.5000 Manufacture of medical and dental instruments and supplies

VIVOSTAT A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  0.8% 3.4% 0.5% 0.5% 0.5%  
Credit score (0-100)  92 54 99 98 99  
Credit rating  AA BBB AA AA AAA  
Credit limit (kDKK)  2,371.7 0.0 3,158.8 3,095.8 3,223.7  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  11,516 5,353 14,000 13,468 13,997  
EBITDA  4,254 -1,953 6,384 6,606 5,833  
EBIT  3,448 -2,373 5,815 5,062 4,184  
Pre-tax profit (PTP)  3,407.0 -2,469.5 5,668.0 4,899.0 4,102.8  
Net earnings  3,407.0 -2,469.5 5,668.0 4,899.0 4,102.8  
Pre-tax profit without non-rec. items  3,407 -2,470 5,668 4,899 4,103  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  1,355 1,215 1,297 1,781 1,868  
Shareholders equity total  21,245 18,776 24,444 24,343 26,946  
Interest-bearing liabilities  1.2 0.8 1,158 32.2 36.2  
Balance sheet total (assets)  23,416 29,159 29,377 26,499 30,455  
Net Debt  -8,013 -16,323 -3,421 -4,788 -1,705  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  11,516 5,353 14,000 13,468 13,997  
Gross profit growth  0.3% -53.5% 161.5% -3.8% 3.9%  
Employees  10 10 10 9 9  
Employee growth %  11.1% 0.0% 0.0% -10.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  23,416 29,159 29,377 26,499 30,455  
Balance sheet change%  10.0% 24.5% 0.7% -9.8% 14.9%  
Added value  4,254.2 -1,953.1 6,384.4 5,631.2 5,833.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -241 -416 2,307 1,279 1,075  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  29.9% -44.3% 41.5% 37.6% 29.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.5% -9.0% 19.9% 18.1% 14.7%  
ROI %  17.1% -11.9% 26.2% 20.3% 16.3%  
ROE %  16.8% -12.3% 26.2% 20.1% 16.0%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  90.7% 64.4% 83.2% 91.9% 88.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -188.3% 835.7% -53.6% -72.5% -29.2%  
Gearing %  0.0% 0.0% 4.7% 0.1% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  420.3% 9,378.2% 25.5% 27.7% 269.3%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  7.0 2.1 3.7 5.7 3.9  
Current Ratio  9.6 2.6 4.9 8.5 5.6  
Cash and cash equivalent  8,014.0 16,323.8 4,578.4 4,820.1 1,741.3  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  18,744.4 16,272.3 19,061.8 16,116.5 15,989.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  425 -195 638 626 648  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  425 -195 638 734 648  
EBIT / employee  345 -237 582 562 465  
Net earnings / employee  341 -247 567 544 456